Strategic transformation
October 2022
Building an organisation for the ecosystem era: Weighing up the Recipe of Haier’s Internet of Food
By Michael Jacobides, Tom Albrighton, Monwei Chou, Lisa Duke, Dalbert Ma, Aryan Mittal
Ecosystems offer a new way to bring multiple firms together in order to deliver new value propositions. By working together, the hub firm and its complementors can create innovative ‘product plus service’ bundles that span traditionally separate industries to offer an experience that simply wasn...
October 2022
From Products to Experience Ecosystems: Haier’s Internet of Food
By Michael Jacobides, Lisa Duke, Dalbert Ma, Aryan Mittal
Haier had come a long way since Zhang Ruimin took it over as a failing Chinese Collective-Owned Enterprise in 1984. Since then, he’d been able to transform it into one of the world’s leading appliance manufacturers, known for quality and innovation. Haier was also noted for its bold geographical...
March 2022
Refinitiv: A private equity-led transformation
By Julian Birkinshaw, David Craig
In August 2019 CEO David Craig was considering the likely benefits and challenges of merging his company, financial-markets data and infrastructure provider Refinitiv, with the London Stock Exchange Group. Craig had led a turnaround of Thomson Reuters’ Financial & Risk division (F&R), then...
October 2020
Takeda: The governance of strategic transformation (B) (Japanese)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to three therapeutic areas, reorganised its global R&D fo...
October 2020
Takeda: The Governance of Strategic Transformation (A) (Japanese)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to three therapeutic areas, reorganised its global R&D fo...
November 2018
Takeda: The governance of strategic transformation (B)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to three therapeutic areas, reorganised its global R&D fo...
November 2018
Takeda: The governance of strategic transformation (A)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to three therapeutic areas, reorganised its global R&D fo...